Release Date: 30/10/09 18:16 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 22.54KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%